IDIZOLE CAP.

Efficacy/Effectiveness

- Vulvovaginal candidiasis
- Oral candidiasis
- Dermatophytoses caused by organisms susceptible to itraconazole (Trichophyton spp., Microsporum spp., Epidermophyton floccosum) e.g. tinea pedis, tinea cruris, tinea corporis, tinea manuum,
- Pityriasis versicolor,
- Onychomycoses caused by dermatophytes and/or yeasts,
- Systemic candidiasis,
- Cryptococcal infections (including cryptococcal meningitis). In immunosuppressed patients suffering from cryptococcosis and in patients with cryptococcosis of the CNS Itraconazole is indicated only if the usually recommended initial therapy seems to be inappropriate or ineffective
- Histoplasmosis.
- Aspergillosis. Itraconazole can be used to treat patients suffering from invasive aspergillosis who were found to be refractory or intolerant to Amphotericin B